TRIMARCHI THOMAS (President and CFO) sold 3.9% of their position (13.60K shares) of BRIDGEBIO PHARMA, INC. on the open market
Open‑market sale worth $1.02M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/18/2026ACC: 0001470831-26-000184
Officer· President and CFO
Since Feb 2026
-32.42K
Net shares
Net seller
$2.43M
Total sold
2
Open market trades
0B · 2S
3
Total transactions
32.42K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−18.82K
Price / share
$75.25
Trade value
$1.42M
% of position
5.1%
2/16/2026
369K→350.19K
Common Stock
Direct
Shares
−13.40K
Price / share
$74.71
Trade value
$1M
% of position
3.8%
2/17/2026
350.19K→336.79K
Common Stock
Direct
Shares
−200.00
Price / share
$75.38
Trade value
$15.08K
% of position
0.1%
2/17/2026
336.79K→336.58K
Total
Net shares
−32.42K
Net value
-$2.43M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/16/2026 | F · Tax Withholding | −18.82K | $75.25 | $1.42M | 5.1% | 369K | 350.19K |
| Common Stock Direct | 2/17/2026 | S · Sale | −13.40K | $74.71 | $1M | 3.8% | 350.19K | 336.79K |
| Common Stock Direct | 2/17/2026 | S · Sale | −200.00 | $75.38 | $15.08K | 0.1% | 336.79K | 336.58K |
| Total | −32.42K | -$2.43M | ||||||
Derivative Transactions0
No derivative transactions reported